TREATMENT OF ESSENTIAL THROMBOCYTHEMIA IN PATIENTS AT LOW AND HIGH-RISK OF THROMBOSIS - A PROSPECTIVE-STUDY

被引：0
|
作者：
FINAZZI, G
CORTELAZZO, S
RUGGERI, M
VESTRI, O
GALLI, M
RODEGHIERO, F
BARBUI, T
机构：
[1] OSPED RIUNITI BERGAMO,DIV HEMATOL,I-24100 BERGAMO,ITALY
[2] OSPED CIVILE,DIV HEMATOL,VICENZA,ITALY
来源：
THROMBOSIS AND HAEMOSTASIS | 1995年 / 73卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：956 / 956
页数：1
相关论文
共 50 条
  • [31] SELECTION OF VARIABLES IN A PROSPECTIVE-STUDY OF YOUNG MEN AT HIGH-RISK FOR ALCOHOLISM
    KNOP, J
    [J]. ACTA PSYCHIATRICA SCANDINAVICA, 1980, 62 : 347 - 352
  • [32] A PROSPECTIVE-STUDY OF TRANSLUMINAL EXTRACTION ATHERECTOMY IN HIGH-RISK PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION
    LARKIN, TJ
    ONEILL, WW
    SAFIAN, RD
    SCHREIBER, TL
    MAY, MA
    KAZZIHA, S
    NIEMYSKI, PR
    PARKER, MA
    KRAMER, BL
    GRINES, CL
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, : A226 - A226
  • [33] Low Thrombosis Risk CALR Mutations Confer Higher Risk of Essential Thrombocythemia Progression
    Erdos, Katie
    Neville, Lee, Jr.
    Lebbe, Ahamed
    Bouhali, Imane
    Khalid, Mohammed
    Abu-Zeinah, Ghaith
    Silver, Richard T.
    Scandura, Joseph M.
    [J]. BLOOD, 2023, 142
  • [34] The risk of thrombosis in essential thrombocythemia and polycythemia vera
    Pearson, TC
    [J]. SEMINARS IN ONCOLOGY, 2002, 29 (03) : 16 - 21
  • [35] Clonal hemapoiesis and risk of thrombosis in young female patients with essential thrombocythemia
    Chiusolo, P
    La Barbera, EO
    Laurenti, L
    Piccirillo, N
    Sorà, F
    Giordano, G
    Urbano, R
    Mazzucconi, MG
    De Stefano, V
    Leone, G
    Sica, S
    [J]. EXPERIMENTAL HEMATOLOGY, 2001, 29 (06) : 670 - 676
  • [36] Risk factors for recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia
    韩雪
    [J]. China Medical Abstracts (Internal Medicine), 2019, 36 (02) : 120 - 121
  • [37] The importance of cardiovascular risk factors for thrombosis prediction in patients with essential thrombocythemia
    Lekovic, Danijela
    Gotic, Mirjana
    Milic, Natasa
    Miljic, Predrag
    Mitrovic, Mirjana
    Cokic, Vladan
    Elezovic, Ivo
    [J]. MEDICAL ONCOLOGY, 2014, 31 (10) : 1 - 6
  • [38] The importance of cardiovascular risk factors for thrombosis prediction in patients with essential thrombocythemia
    Danijela Lekovic
    Mirjana Gotic
    Natasa Milic
    Predrag Miljic
    Mirjana Mitrovic
    Vladan Cokic
    Ivo Elezovic
    [J]. Medical Oncology, 2014, 31
  • [39] Risk of thrombosis in patients with essential thrombocythemia and type 1 CALR mutation
    Kawada, Tomoyuki
    [J]. THROMBOSIS RESEARCH, 2022, 212 : 4 - 4
  • [40] A multicenter, open-label study for efficacy and safety evaluation of anagrelide in patients with treatment-naive, high-risk essential thrombocythemia as a primary treatment
    Byun, Ja Min
    Kim, Ho Young
    Nam, Seung-Hyun
    Shin, Ho-Jin
    Song, Seulki
    Park, Jinny
    Han, Sang Hoon
    Park, Yong
    Yuh, Young Jin
    Mun, Yeung-Chul
    Do, Young Rok
    Sohn, Sang Kyun
    Bae, Sung Hwa
    Shin, Dong-Yeop
    Yoon, Sung-Soo
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
12345